BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · IEX Real-Time Price · USD
5.08
-0.07 (-1.36%)
At close: Mar 28, 2024, 4:00 PM
5.09
+0.01 (0.20%)
After-hours: Mar 28, 2024, 6:30 PM EDT

BioCryst Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1994
Revenue
331.41270.83157.1717.8148.8420.6525.1926.3548.2613.61
Upgrade
Revenue Growth (YoY)
22.37%72.31%782.38%-63.53%136.45%-18.00%-4.43%-45.39%254.62%-21.48%
Upgrade
Cost of Revenue
4.666.597.261.684.10.471.72.71.90.12
Upgrade
Gross Profit
326.75264.23149.9116.1444.7320.1823.4823.6546.3613.49
Upgrade
Selling, General & Admin
213.89159.37118.8267.9337.1229.5113.9311.2513.057.46
Upgrade
Research & Development
216.57253.3208.81122.96107.0784.8966.9661.0172.7651.8
Upgrade
Operating Expenses
430.46412.67327.63190.89144.19114.480.972.2685.8159.26
Upgrade
Operating Income
-103.71-148.44-177.72-174.76-99.46-94.22-57.41-48.61-39.44-45.77
Upgrade
Interest Expense / Income
108.2499.0959.2914.511.899.188.576.495.25
Upgrade
Other Expense / Income
14.28-3.14-55.21-6.44-2.45-2.14-0.190.05-1.63-5.58
Upgrade
Pretax Income
-226.23-244.38-181.81-182.81-108.9-101.25-65.78-55.14-43.02-45.19
Upgrade
Income Tax
0.312.732.250000000
Upgrade
Net Income
-226.54-247.12-184.06-182.81-108.9-101.25-65.78-55.14-43.02-45.19
Upgrade
Shares Outstanding (Basic)
19218617916711610384747367
Upgrade
Shares Outstanding (Diluted)
19218617916711610384747367
Upgrade
Shares Change
3.38%3.79%7.08%44.69%12.03%22.18%14.59%1.09%9.18%20.93%
Upgrade
EPS (Basic)
-1.18-1.33-1.03-1.09-0.94-0.98-0.78-0.75-0.59-0.68
Upgrade
EPS (Diluted)
-1.18-1.33-1.03-1.09-0.94-0.98-0.78-0.75-0.59-0.68
Upgrade
Free Cash Flow
-97.31-163.2-144.54-135.62-89.93-92.93-41.46-58.71-18.24-38.66
Upgrade
Free Cash Flow Per Share
-0.51-0.88-0.81-0.81-0.78-0.90-0.49-0.80-0.25-0.58
Upgrade
Gross Margin
98.59%97.57%95.38%90.59%91.60%97.72%93.24%89.76%96.07%99.10%
Upgrade
Operating Margin
-31.29%-54.81%-113.08%-981.12%-203.66%-456.20%-227.95%-184.45%-81.74%-336.35%
Upgrade
Profit Margin
-68.36%-91.24%-117.11%-1026.35%-222.99%-490.25%-261.18%-209.25%-89.15%-332.08%
Upgrade
Free Cash Flow Margin
-29.36%-60.26%-91.97%-761.41%-184.14%-449.96%-164.61%-222.79%-37.79%-284.08%
Upgrade
EBITDA
-116.34-143.85-121.74-167.57-96.28-91.31-56.51-48.17-37.64-40.01
Upgrade
EBITDA Margin
-35.10%-53.12%-77.46%-940.74%-197.16%-442.10%-224.38%-182.80%-78.00%-294.05%
Upgrade
Depreciation & Amortization
1.661.440.780.750.720.770.70.480.180.18
Upgrade
EBIT
-117.99-145.29-122.52-168.31-97.01-92.08-57.22-48.66-37.82-40.19
Upgrade
EBIT Margin
-35.60%-53.65%-77.95%-944.94%-198.64%-445.82%-227.18%-184.64%-78.37%-295.35%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).